Browsing Tag
Verrica Pharmaceuticals
2 posts
Verrica’s SITC reveal: can VP-315’s immune activation data reshape the skin cancer treatment landscape
Find out how Verrica’s VP-315 immune activation data at SITC 2025 could redefine non-surgical skin cancer treatment options for dermatologic oncology.
October 8, 2025
Verrica Pharmaceuticals shares plummet after shocking 3Q results and massive restructuring
Shares of Verrica Pharmaceuticals Inc. faced a sharp decline after the company disclosed disappointing third-quarter 2024 financial results…
November 5, 2024